Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnetically-enhanced radionuclide therapy (MERiT): in vitro evaluation

R R Raylman1, A C Clavo, S C Crawford

  • 1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA. rraylman@wvuhsc1.hsc.wvu.edu

International Journal of Radiation Oncology, Biology, Physics
|March 15, 1997
PubMed
Summary

Magnetically-enhanced radionuclide therapy (MERiT) uses magnetic fields to improve radiation delivery to small tumors. This technique confines electrons, increasing tumor dose and protecting surrounding healthy tissues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construction and evaluation of a large radiation detector for Positron Emission Tomography applications.

Journal of instrumentation : an IOP and SISSA journal·2025
Same author

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022
Same author

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.

European journal of nuclear medicine and molecular imaging·2022
Same author

Evaluation of Hamamatsu PET imaging modules for dedicated TOF-capable scanners.

IEEE transactions on radiation and plasma medical sciences·2021
Same author

Factors affecting the repeatability of gamma camera calibration for quantitative imaging applications using a sealed source.

Physics in medicine and biology·2015
Same author

Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer.

Practical radiation oncology·2014

Area of Science:

  • Nuclear Medicine
  • Medical Physics
  • Oncology

Background:

  • Radionuclide therapy offers targeted radiation delivery to tumors.
  • Electron-emitting radionuclides can deliver sub-optimal doses to small tumors due to electron escape.
  • Magnetic fields can potentially confine electrons, enhancing dose deposition.

Purpose of the Study:

  • To investigate the efficacy of magnetically-enhanced radionuclide therapy (MERiT) for small tumors.
  • To evaluate the ability of magnetic fields to constrain electron emissions.
  • To assess the biological impact of MERiT on cancer cells in vitro.

Main Methods:

  • Measured electron energy deposition in a 90Y-containing sphere within a 7 Tesla magnetic field.
  • Compared energy deposition inside and outside the magnetic field using plastic scintillators.

Related Experiment Videos

  • Exposed human lymphoma cells with 90Y-labeled albumin to a 7 Tesla magnetic field for 18 hours.

    • Main Results:

    • A 7 Tesla magnetic field reduced electron energy deposition by 16.63 +/- 1.05%, indicating electron confinement.
    • MERiT significantly reduced viable lymphoma cells by 11.7% (p < 0.005) compared to controls.
    • Magnetic confinement of electrons increases radiation dose to the target volume.

    Conclusions:

    • Magnetically-enhanced radionuclide therapy (MERiT) shows promise for increasing radiation dose to small tumors.
    • MERiT can potentially reduce radiation exposure to normal tissues adjacent to tumors.
    • Initial physical and biological data support the effectiveness of MERiT.